David P. Meeker

2020

In 2020, David P. Meeker earned a total compensation of $14.3M as Chief Executive Officer at RHYTHM PHARMACEUTICALS.

Compensation breakdown

Non-Equity Incentive Plan$207,958
Option Awards$12,844,897
Salary$262,308
Stock Awards$918,500
Other$43,704
Total$14,277,367

Meeker received $12.8M in option awards, accounting for 90% of the total pay in 2020.

Meeker also received $208K in non-equity incentive plan, $262.3K in salary, $918.5K in stock awards and $43.7K in other compensation.

Rankings

In 2020, David P. Meeker's compensation ranked 446th out of 13,090 executives tracked by ExecPay. In other words, Meeker earned more than 96.6% of executives.

ClassificationRankingPercentile
All
446
out of 13,090
97th
Division
Manufacturing
152
out of 5,618
97th
Major group
Chemicals And Allied Products
51
out of 2,251
98th
Industry group
Drugs
45
out of 1,951
98th
Industry
Pharmaceutical Preparations
32
out of 1,456
98th
Source: SEC filing on April 27, 2023.

Meeker's colleagues

We found two more compensation records of executives who worked with David P. Meeker at RHYTHM PHARMACEUTICALS in 2020.

2020

Hunter Smith

RHYTHM PHARMACEUTICALS

Chief Financial Officer

2020

Jennifer Chien

RHYTHM PHARMACEUTICALS

Executive Vice President, Head of North America

News

In-depth

You may also like